El.En. S.p.A.
15.50
EUR
-0.25
(-1.59%)
ISIN
IT0005453250
Return %
Stock
S&P 500
1Y
34.90
14.20
3Y
85.41
81.12
5Y
-11.93
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Quarterly Revenue
EUR
•
in mil. unless spec.Quarterly Earnings Per Share
EUR
•
in mil. unless spec.Quarterly Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Gabriele Clementi
- Full Time Employees
- 1,412
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Via Baldanzese 17 Calenzano FI Italy 50041
- IPO Date
- Dec 4, 2000
- Website
- elengroup.com
- Similar Companies
- Business
- El.En. S.p.A. engages in the design, production, and marketing of laser sources and laser equipment for medical, aesthetic, industrial, and cultural heritage applications. The company’s core products include medical laser devices used in dermatology, surgery, aesthetics, physiotherapy, dentistry, urology, and gynecology; industrial laser systems for cutting, marking, welding, and engraving metals, plastics, wood, glass, leather, paper, cardboard, and fabrics; and laser technologies for the conservative restoration of artworks. It also offers after-sales assistance and develops advanced laser systems such as sealed-off and self-refilling RF CO₂ lasers, fiber galvo scanners, and OEM laser solutions. El.En. operates internationally, with a presence across Europe, America, and Asia, and maintains a broad portfolio designed to enhance efficiency, productivity, and performance in various industries. Founded in 1981 and headquartered in Calenzano, Italy, El.En. leads an international group of high-tech companies in optoelectronics. Recent major changes include robust growth in the medical sector marked by increased sales in high-margin categories like anti-aging treatments and surgical laser systems, especially in urology. The company has been actively expanding its capacity in optical fibers to meet future demand. Although the industrial division faced challenges with delayed revenues and weaker performance, ongoing strategic efforts focus on bolt-on acquisitions in both medical and industrial fields primarily within Europe and globally. Additionally, El.En. has divested a majority stake in one of its subsidiaries to strengthen cash flow and reinforce financial positioning. The company continues to prioritize research and development for continuous innovation, aiming to introduce new laser applications and technologies. It maintains a strong commitment to social responsibility, customer support, and environmental sustainability. El.En. distributes its products globally with a comprehensive network and serves a wide range of professional customers, including medical practitioners, industrial manufacturers, and cultural heritage conservation specialists. Its solutions encompass advanced medical laser systems, high-power industrial lasers, and specialized equipment for art restoration to improve quality of life and operational productivity worldwide.
Company News
EL.En. S.p.A. (ELEAF) Q2 2026 Earnings Call Transcript
EL.En. S.p.A. (ELEAF) Q1 2026 Earnings Call Transcript
EL.En. S.p.A. (ELEAF) Q4 2025 Earnings Call Transcript
EL.En. S.p.A. (ELEAF) Q3 2025 Earnings Call Transcript
After the Great Success Achieved in the United States and Canada, DEKA Launches Three Extraordinary Laser and Microwave Platforms at the World Congress of Dermatology in Singapore